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OBJECTIVES: No method exists for measuring cost-
effectiveness of services rendered to patients throughout the con-
tinuum of care. Products categorized within the durable medical
equipment (DME) beneﬁt add another complicating factor in
determining the economic value of therapies. The objective of
this study is to determine the cost-effectiveness of V.A.C.®
Therapy compared to standard wound treatment for a dehisced
chest wound patient treated across the continuum of care.
METHODS: Treatment ﬂows were determined through analyses
of clinical literature and veriﬁed by physicians. An economic
model was constructed using data from published literature to
determine events and transition probabilities. Publicly available
sources were used to determine clinical outcomes, hospital days,
nursing time, and costs. A claims database was used for home
care information. Meta-analyses served to integrate disparate
data sources, (e.g., by calculating weighted averages). RESULTS:
The economic model estimated the potential cost savings greater
than $8500 for treating dehisced chest wound patients with
V.A.C.® Therapy when compared to wet-to-moist dressings. The
return on investment (ROI deﬁned as potential savings divided
by material costs for V.A.C.® Therapy,) is calculated to be $6.68:
$1. This ﬁgure suggests that every dollar spent on V.A.C.®
Therapy may be associated with more than $6 potential savings.
The largest factor contributing to the cost-effective outcomes of
V.A.C.® Therapy was the number of hospital days. V.A.C.®
Therapy was associated with an estimated 5.2 fewer days com-
pared to wet-to-moist therapy. The difference in closure method
(e.g., primary closure instead of ﬂap, secondary closure instead
of primary closure) was the second largest contributor to 
the model results. CONCLUSIONS: This study suggests that
V.A.C.® Therapy for a dehisced chest wound may provide a
potential cost savings when compared to wet-to-moist treat-
ments. These results highlight the importance of assessing wound
therapy based on cost-effectiveness and ROI rather than on daily
DME cost.
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OBJECTIVES: To conduct the ﬁrst randomized controlled trial
comparing the cost-effectiveness of From Home To Operation
(FHTO) and conventional process in laparoscopic cholecystec-
tomy (LC). METHODS: In Finnish communal hospitals, the
patient is typically admitted to hospital on the preoperative day
if he/she is not suitable for day-case. Between 12/2004–7/2005,
47 patients with symptomatic gallstones who were scheduled 
for LC were randomized to be operated either as FHTO (28
patients) or in the conventional way (19 patients) in Hyvinkää
hospital. The quality of life (QoL) was measured with the 15D.
Adjustments regarding baseline QoL, age, gender, BMI, ASA
group, and smoking were conducted with robust iterative regres-
sion (Huber/Tukey) for quality adjusted life years (QALY) gained
and with a robust generalized linear model (GLM, gamma dis-
tribution; log-link) for costs. A stochastic approach with one
month interval for costs, length of postoperative stay, infection
rate, and QALYs was employed. RESULTS: Baseline group char-
acteristics were similar. The mean health care costs in the FHTO
(1695 EUR) were signiﬁcantly lower (p < 0.001) than in the con-
ventional arm (2234 EUR). The number of patients discharged
on the ﬁrst postoperative day was 27 (96.4%) and 15 (78.9%)
with the number of infections being 2 (7.1%) in the FHTO group
and 4 (21.1%) in the conventional group. A signiﬁcant differ-
ence in QALYs gained (0.01742, p = 0.030) favouring the FHTO
was observed between the two arms. Assuming a willingness-to-
pay of 5000 EUR per QALY, the probability of FHTO falling
below this threshold value was 99%. This result was robust to
sensitivity analyses. CONCLUSIONS: The FHTO dominated the
conventional process in LC. After the initial investments, a
Finnish hospital performing 500 standard LCs per year may
produce 8 more QALYs, introduce 69 fewer infections and expe-
rience potential cost savings of 280000 EUR or require 667
fewer hospital days with the FHTO.
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OBJECTIVE: Increasing funding constraints have resulted in
considerable pressure to improve the cost-effectiveness of solid
organ transplant programs. Such efforts require an understand-
ing of factors driving costs. To date, however, few investigators
have examined the impact of patient characteristics on the
resources utilized for transplantation. The aim was to determine
the impact of demographic characteristics of patients on the on
the mean direct medical costs of care during each of the two
years post-transplant. METHODS: Using the Ministry of Health
perspective, direct medical costs of all persons undergoing a
transplantation of kidney, lung, heart or liver, were determined
using data from British Columbia between 1995 and 2003.
Health resources categories included inpatient hospital stays,
outpatient visits, physician fees, laboratory and diagnostic tests
and immunosuppressant medications. Multivariate analysis was
used to model the impact of age, sex, and an indirect measure
of median household income, on the costs of caring for patients
during each of the two years post-transplant, after adjusting for
calendar period. RESULTS: The percentage of women undergo-
ing each procedure was 41% for kidney (n = 876 procedures),
40% liver (n = 257), 39% for lung (n = 67) and 23% for heart
transplants (n = 133). After adjusting for calendar period, there
was no impact of age or median household income on treatment
costs during either the ﬁrst or second years of follow-up after
transplant. For persons undergoing lung transplantation, the
mean costs of follow-up were signiﬁcantly increased among men,
with no differences in costs observed between women and men
undergoing kidney, heart, or liver transplant. CONCLUSION:
We observed that, among persons undergoing solid organ trans-
plantation in BC, demographic characteristics did not have a sys-
tematic inﬂuence on the direct medical costs of post transplant
care. Patient-speciﬁc clinical factors likely play a greater role in
determining costs.
